Scandion Oncology A/S (SCOL.ST)
SEK 0.01
(4.39%)
SEK 0.01
(4.39%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 205.44 Thousand | - |
| Cost of Revenue | - | - | - | - | 11.36 Million | 7.38 Million |
| Gross Profit | - | - | - | - | -11.16 Million | -7.38 Million |
| Operating Expenses | 45.35 Million | 80.16 Million | 55.36 Million | 22.88 Million | 15.39 Million | 2.54 Million |
| Selling, General and Administrative Expenses | 13.95 Million | 7.01 Million | 3.13 Million | 14.45 Million | 11.36 Million | 2.54 Million |
| Research and Development Expenses | 31.85 Million | 65.06 Million | 47.71 Million | 21.67 Million | - | - |
| Other Expenses | -446 Thousand | 8.09 Million | 4.52 Million | 8.42 Million | 4.03 Million | 2.54 Million |
| Cost and Expenses | 45.35 Million | 80.16 Million | 55.36 Million | 22.88 Million | 15.39 Million | 2.54 Million |
| Operating Income | -45.35 Million | -80.16 Million | -55.36 Million | -22.88 Million | -15.39 Million | -9.93 Million |
| Interest Expense | - | 495 Thousand | 767 Thousand | 42 Thousand | 165.98 Thousand | 23.32 Thousand |
| Income Tax Expense | 5.5 Million | -5.5 Million | -5.5 Million | -4.38 Million | -3.37 Million | -1.77 Million |
| Earnings before Tax | -44.7 Million | -82.2 Million | -57.21 Million | -20.65 Million | -15.55 Million | -9.95 Million |
| Net Income | -39.2 Million | -76.7 Million | -51.7 Million | -16.26 Million | -12.18 Million | -8.18 Million |
| Earnings Per Share Basic | -0.96 | -1.79 | -1.61 | -0.51 | -0.81 | -0.80 |
| Earnings Per Share Diluted | -0.96 | -1.79 | -1.54 | -0.50 | -0.81 | -0.80 |
| Weighted Average Shares Outstanding | 40.7 Million | 42.92 Million | 32.13 Million | 32.13 Million | 15.04 Million | 10.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 40.7 Million | 42.92 Million | 33.63 Million | 32.32 Million | 15.04 Million | 10.24 Million |
| Gross Margin | - | - | - | - | -54.32 | - |
| EBIT Margin | - | - | - | - | -74.87 | - |
| Profit Margin | - | - | - | - | -59.30 | - |
| EBITDA | -45.53 Million | -80.82 Million | -56.09 Million | -22.85 Million | -15.59 Million | - |
| Earnings Before Tax Margin | - | - | - | - | -74.92 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 9.35 Million | 10.09 Million | 11.58 Million | 44.79 Million | 10.91 Million | 11.31 Million |
| Selling, General and Administrative Expenses | 3.68 Million | 3.78 Million | -1.64 Million | - | 2.05 Million | 3.5 Million |
| Research and Development Expenses | 5.67 Million | 6.31 Million | 4.37 Million | - | 8.66 Million | 8.32 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 9.35 Million | 10.09 Million | 11.58 Million | 44.79 Million | 10.91 Million | 11.31 Million |
| Operating Income | -9.35 Million | -10.1 Million | -11.15 Million | -45.8 Million | -10.91 Million | -11.31 Million |
| Interest Expense | 54 Thousand | 131 Thousand | -719 Thousand | - | 218 Thousand | 269 Thousand |
| Income Tax Expense | -1.96 Million | -2.33 Million | -553 Thousand | 5.5 Million | -402 Thousand | -2.47 Million |
| Earnings before Tax | -9.13 Million | -9.9 Million | -10.98 Million | -44.7 Million | -10.55 Million | -11.25 Million |
| Net Income | -7.16 Million | -7.56 Million | -10.98 Million | -39.2 Million | -10.15 Million | -8.77 Million |
| Earnings Per Share Basic | -0.18 | -0.19 | -0.27 | - | -0.25 | -0.22 |
| Earnings Per Share Diluted | -0.18 | -0.19 | -0.27 | - | -0.25 | -0.22 |
| Weighted Average Shares Outstanding | 39.83 Million | 39.83 Million | 40.7 Million | 40.7 Million | 40.61 Million | 39.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 39.83 Million | 39.83 Million | 40.7 Million | 40.7 Million | 40.61 Million | 39.88 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -8.96 Million | -9.66 Million | -11.44 Million | - | -10.11 Million | -10.73 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
2722
KLBN3
3RB
1140
002810
TAWNF